SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is seeing significant bullish momentum after a short-seller retracted serious allegations against a major shareholder, driving a rebound and sparking community discussion around an imminent short squeeze and anticipated strong earnings.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio Inc. is trending after the FDA issued a Complete Response Letter (CRL) for its RGX-121 gene therapy, citing trial design concerns and intensifying community discussion around the stringent regulatory environment for gene therapies. While many anticipate further stock depreciation and question the company's outlook, some investors highlight other pipeline assets as potential future drivers.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant discussion as investors grapple with its recent price action ahead of its upcoming Q4 earnings report. Community sentiment is split between those who view its AI-powered lending model as massively undervalued given its profitability and prudent risk management, and others concerned by its conservative growth outlook and the broader fintech sector's current struggles.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is trending following a significant sell-off after it issued weaker-than-expected revenue guidance, intensifying broader market concerns that AI tools could disrupt traditional software business models. The community is divided, with many calling the drop an overreaction and a buying opportunity, while others believe AI will render such platforms obsolete.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is gaining significant attention following its pre-announcement of substantially raised revenue guidance for fiscal year 2026, driven by strong demand in the AI infrastructure buildout. The community is actively discussing its position as a key "picks and shovels" beneficiary of massive hyperscaler capital expenditures, despite recent price volatility and ongoing debates around its core technology and insider share sales.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending due to its latest earnings, where a revenue miss and softer forward guidance, particularly against a backdrop of ongoing automotive market softness, have disappointed investors. Community discussion centers on the company's valuation, perceived lack of growth beyond pure AI chip plays, and the broader impact of the EV sector slowdown.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings Inc. is trending sharply lower after the abrupt departures of its CFO and general counsel amid an accounting review and delayed regulatory filings, prompting community discussions ranging from severe financial irregularity concerns to perceptions of an extreme, oversold market reaction.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is seeing heightened discussion ahead of its earnings report, as the community debates whether its perceived undervaluation and recent insider buying will spark a rebound or if previous guidance adjustments and broader fintech sector concerns will lead to another significant decline.

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

AgomAb Therapeutics NV - ADR

AGMB is trending as a recent IPO, driving community discussion around its low float and market cap, with some anticipating a significant move higher while others expect a pullback after an initial run.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending after reporting a significant earnings beat and robust revenue guidance, sparking community discussion around its substantial advanced packaging investments for AI and compute, which are strongly supported by CHIPS Act funding.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Significant Decline in Short Interest

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Large Increase in Short Interest

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest...

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Update

Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short...

Radiopharm Theranostics (NASDAQ:RADX) Earns "Buy" Rating from B. Riley

B. Riley restated a "buy" rating and set a $16.00 price objective (up previously from $13.00) on shares of Radiopharm Theranostics in a report on Tuesday...

<ul class="summary-bullets"><li>iRobot shares were down more than 73% in Monday’s midday session after the company filed for Chapter 11 bankruptcy on Sunday.</li><li>ServiceNow shares were down by more than 11% in Monday’s midday session after a report stated that the company was looking to acquire cybersecurity startup Armis in a $7 billion deal.</li><li>Radiopharm Theranostics shares soared more than 181% in Monday’s midday trade after the company announced that 92% of patients treated with RAD 101 achieved the primary endpoint.</li></ul>U.S. equities were in the red in Monday’s midday trade as investors exercised caution ahead of the release of key economic data this week, which could offer clues about the Federal Reserve’s policy trajectory in 2026.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was down 0.11% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, declined 0.21%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, fell 0.17%.<h2 class="st-heading-2">Here are the top stocks making the biggest moves in Monday’s midday trade:</h2><a href="https://stocktwits.com/symbol/TSLA">Tesla Inc. (TSLA)</a>Tesla shares were up nearly 4% in Monday’s midday trade after CEO Elon Musk&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dan-ives-tesla-market-cap-double-to-3-trillion-2026/cLe4bGyRE8w">stated</a> in a post on Sunday that the EV giant had begun fully autonomous testing of Robotaxis in Austin.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> is up 18% year-to-date.<a href="https://stocktwits.com/symbol/IRBT">iRobot Corp. (IRBT)</a>iRobot shares were down more than 73% in Monday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/irobot-vacuumed-up-the-market-with-its-roomba-but-quickly-ran-out-of-power-after-a-failed-amazon-deal/cLeEDVARE88">filed</a> for Chapter 11 bankruptcy on Sunday. The company said it would be acquired by its China-based contract manufacturer and lender, Shenzhen Picea Robotics.<a href="https://stocktwits.com/symbol/IRBT">IRBT stock</a> is down 85% year-to-date.<a href="https://stocktwits.com/symbol/NOW">ServiceNow Inc. (NOW)</a>ServiceNow shares were down by more than 11% in Monday’s midday session after a report stated that the company was&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/servicenow-stock-is-down-5-percent-today-whats-weighing-on-the-shares/cLe42UmREoE">looking</a> to acquire cybersecurity startup Armis in a $7 billion deal.<a href="https://stocktwits.com/symbol/NOW">NOW stock</a> is down 27% year-to-date.<a href="https://stocktwits.com/symbol/RADX">Radiopharm Theranostics (RADX)</a>Radiopharm Theranostics shares soared more than 181% in Monday’s midday trade after the company announced that 92% of patients treated with RAD 101 achieved the primary endpoint, showing significant and selective tumor uptake in the brain metastases.<a href="https://stocktwits.com/symbol/RADX">RADX stock</a> is up 166% year-to-date.<a href="https://stocktwits.com/symbol/KYTX">Kyverna Therapeutics Inc. (KYTX)</a>Kyverna Therapeutics shares were up nearly 26% in Monday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/kytx-stock-just-surged-11-percent-today-what-is-the-connection-with-stiff-person-syndrome/cLe4RuBRE8U">announced</a> positive topline data from its registrational Phase 2 trial of mivocabtagene autoleucel, a fully human, autologous CD19-targeting CAR T-cell therapy with CD28 co-stimulation, in stiff person syndrome.<a href="https://stocktwits.com/symbol/KYTX">KYTX stock</a> is up 197% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/howard-marks-gold-lackluster-investment-despite-rally-in-2025/cLe47kZREoN">Gold Is Up 65% YTD, But Howard Marks Says The Case For Owning It Can Be ‘Superstition,’ Not Intrinsic Value</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Tesla, iRobot, ServiceNow, Radiopharm Theranostics, Kyverna Therapeutics: Stocks Making The Biggest Moves Today

Tesla shares were up nearly 4% in Monday’s midday trade after CEO Elon Musk stated in a post on Sunday that the EV giant had begun fully autonomous testing of Robotaxis in Austin.

Equity

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

RADX
Radiopharm Theranostics Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest RADX News

RADXRadiopharm Theranostics Ltd - ADR